Kliniske studier sponset av Referral Centre of Reproductive Health, Fez, Morocco
Totalt 1 resultater
-
International Agency for Research on CancerReferral Centre of Reproductive Health, Fez, Morocco; Referral Centre of...Fullført
Denne siden ble automatisk oversatt og nøyaktigheten av oversettelsen er ikke garantert. Vennligst referer til engelsk versjon for en kildetekst.
Sponsorer og samarbeidspartnere
- Greater Baltimore Medical Center
- AsyutUniversity
- SwanBio Therapeutics, Inc.
- HYLAB, Physiopathologie de l'exercice
- ResMed Canada Inc.
- QuintilesIMS, Inc.
- Mustafakemalpasa State Hospital
- Providence St. Vincent Department of Medicine
- Mokpo National University
- Japan Clinical Cancer Research Organization
- Resonance Health
- Alliance for Cancer Gene Therapy
- Calvary Health Care Bethlehem
- Antonio Martín Duce
- Zhigang Li
- people's hospital of Guang'an
- ITE College West
- King Saud Bin Abdulaziz University for Health Sciences
- Xu Hong
- arsany botros saleh
- Vis full liste
Medisinsk tilstand
- Combretastatin A4 fosfat
- Avansert thymus epitelial svulst
- Hepatitt A-virusinfeksjon
- Perifer primitiv nevroektodermal beinsvulst
- Inngrodd tånegl
- Diskret valgeksperiment
- Anaplastisk lymfom kinase genmutasjon
- Pesticid-indusert parkinsonisme
- Perifere mikrovaskulære symptomer
- Enkel traumatisk lemskade med alvorlig smerte (score > 5/10 på numerisk smerteskala)
- Eldre mennesker med risiko for hjerte- og karsykdommer
- Orofaryngealt basaloid karsinom
- Ikke-opererbart malignt melanom i stadium III eller IV
- Hudandrogenisering
- Ductal Carcinomas
- Stadium II Eggstokkreft
- Neoplasi; Intraepitelial, Cervix
- Thorarisk kirurgi
- Ondartet svulst
- Stage III melanom
- Vis full liste
Legemiddelintervensjoner
- CHF 5993
- Filgrastim
- Pentoksifyllin
- RAPA114
- Oksykodon
- Sammensatte Azimtamid Entieric-drasjerte tabletter
- Brivaracetam (BRV) tørr sirup
- PF-04965842
- Doksycyklinhyklat
- Isoniazid, Rifampicin, Pyrazinamid og Etambutol
- Humalog®
- Mavacamten
- LUM/IVA
- Trastuzumab
- Arm I (iliopsoas planblokkgruppe)
- OKI-179
- VVN461 Oftalmisk løsning 1,0 %
- Crizotinib
- VX-121 (suspensjon)
- SDP-4 oftalmisk løsning (3,0 %)
- Vis full liste
CROs by country
- Contract Research Organizations in Costa Rica
- Contract Research Organizations in Ecuador
- Contract Research Organizations in Ethiopia
- Contract Research Organizations in Germany
- Contract Research Organizations in Guinea
- Contract Research Organizations in Kenya
- Contract Research Organizations in Kyrgyzstan
- Contract Research Organizations in Latvia
- Contract Research Organizations in Lebanon
- Contract Research Organizations in Malawi
- Contract Research Organizations in Saint Lucia
- Contract Research Organizations in Trinidad & Tobago
- Contract Research Organizations in Ukraine
- CRO list by country